Jump to content
RemedySpot.com

e-discussion on Emerging trends in therapeutics of ACS

Rate this topic


Guest guest

Recommended Posts

Guest guest

Dear Members,Acute

coronary syndrome (ACS), including both ST-elevation myocardial infarction

(STEMI) and non-ST elevation ACS (NSTE-ACS), is an important manifestation of IHD. Rapid diagnosis and treatment with

appropriate reperfusion therapies has been proven to increase survival for

patients with STEMI. This benefit of

reperfusion diminishes as the interval from time of symptom onset to initiation

of therapy increases.Current ACS guidelines

emphasize the importance of rapid hospital care, especially for STEMI patients

who may be eligible for thrombolytic reperfusion within the first twelve hours.RegardsTarun Wadhwa

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...